Zevenbergen Capital Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Sell
9,989
-10
-0.1% -$3.42K 0.08% 74
2026
Q1
$3.52M Buy
9,999
+40
+0.4% +$14.3K 0.1% 73
2025
Q4
$3.26M Buy
9,959
+50
+0.5% +$15.9K 0.07% 79
2025
Q3
$2.8M Buy
9,909
+55
+0.6% +$16K 0.05% 80
2025
Q2
$2.75M Buy
9,854
+290
+3% +$82.2K 0.05% 79
2025
Q1
$2.98M Sell
9,564
-255
-3% -$75.3K 0.07% 73
2024
Q4
$2.56M Sell
9,819
-75
-0.8% -$22.3K 0.05% 78
2024
Q3
$3.19M Buy
9,894
+20
+0.2% +$6.54K 0.07% 68
2024
Q2
$3.09M Buy
9,874
+475
+5% +$140K 0.07% 68
2024
Q1
$2.67M Buy
9,399
+25
+0.3% +$7.32K 0.06% 79
2023
Q4
$2.7M Buy
9,374
+1,270
+16% +$346K 0.06% 76
2023
Q3
$2.18M Hold
8,104
0.06% 80
2023
Q2
$1.8M Buy
8,104
+50
+0.6% +$11.6K 0.04% 81
2023
Q1
$1.95M Buy
8,054
+25
+0.3% +$6.14K 0.05% 80
2022
Q4
$2.11M Buy
8,029
+320
+4% +$85.8K 0.07% 80
2022
Q3
$1.74M Buy
7,709
+105
+1% +$25.5K 0.05% 85
2022
Q2
$1.85M Hold
7,604
0.08% 59
2022
Q1
$1.84M Buy
7,604
+610
+9% +$140K 0.05% 60
2021
Q4
$1.57M Sell
6,994
-445
-6% -$93.9K 0.03% 69
2021
Q3
$1.58M Sell
7,439
-25
-0.3% -$5.75K 0.03% 69
2021
Q2
$1.82M Buy
7,464
+715
+11% +$176K 0.03% 69
2021
Q1
$1.68M Buy
6,749
+125
+2% +$29.8K 0.03% 67
2020
Q4
$1.52M Buy
6,624
+1,665
+34% +$384K 0.03% 63
2020
Q3
$1.26M Buy
4,959
+785
+19% +$194K 0.03% 60
2020
Q2
$984K Buy
4,174
+618
+17% +$141K 0.02% 64
2020
Q1
$721K Buy
3,556
+640
+22% +$140K 0.03% 63
2019
Q4
$703K Sell
2,916
-7
-0.2% -$1.54K 0.03% 72
2019
Q3
$566K Buy
2,923
+563
+24% +$108K 0.02% 73
2019
Q2
$435K Sell
2,360
-309
-12% -$55.3K 0.01% 78
2019
Q1
$507K Buy
2,669
+9
+0.3% +$1.72K 0.02% 70
2018
Q4
$518K Buy
2,660
+95
+4% +$18.5K 0.02% 69
2018
Q3
$532K Buy
2,565
+105
+4% +$20.7K 0.02% 75
2018
Q2
$454K Sell
2,460
-105
-4% -$18.6K 0.02% 78
2018
Q1
$437K Sell
2,565
-225
-8% -$41.3K 0.02% 74
2017
Q4
$485K Buy
2,790
+90
+3% +$15.9K 0.02% 74
2017
Q3
$503K Buy
2,700
+140
+5% +$24.8K 0.02% 73
2017
Q2
$441K Sell
2,560
-275
-10% -$44.7K 0.02% 72
2017
Q1
$465K Buy
2,835
+985
+53% +$164K 0.02% 74
2016
Q4
$270K Sell
1,850
-25
-1% -$3.76K 0.01% 78
2016
Q3
$313K Buy
1,875
+220
+13% +$37.2K 0.01% 79
2016
Q2
$252K Buy
+1,655
New +$257K 0.01% 73

Other funds holding AMGN

Zevenbergen Capital Investments's AMGN Position: Q2 2026 in Review

Zevenbergen Capital Investments reduced its Amgen (AMGN) stake by 0.1% in Q2 2026, selling an estimated $3.42K and leaving 9,989 shares worth $3.62M. The position accounts for 0.08% of the portfolio, ranked #74.

Zevenbergen Capital Investments first reported a position in AMGN in Q2 2016 and has held it in 41 quarters since. 1,409 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Zevenbergen Capital Investments held 9,989 shares of Amgen worth $3.62M as of Q2 2026.
  • Zevenbergen Capital Investments sold 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up 0.08% of Zevenbergen Capital Investments's portfolio in Q2 2026, its #74 holding.
  • Zevenbergen Capital Investments first reported a position in Amgen in Q2 2016 and has held it in 41 quarters since.
  • 1,409 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2026, filed 16 Jul 2026.